# Effect of Resveratrol Administration on Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion

> **NCT02114892** · PHASE2 · COMPLETED · sponsor: **University of Guadalajara** · enrollment: 24 (actual)

## Conditions studied

- Metabolic Syndrome X

## Interventions

- **DRUG:** Resveratrol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02114892
- **Lead sponsor:** University of Guadalajara
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2013-07
- **Final completion:** 2013-09
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2020-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02114892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02114892, "Effect of Resveratrol Administration on Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02114892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*